UBS AM’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-67,312
Closed -$419K 2913
2021
Q3
$419K Buy
67,312
+18,418
+38% +$123K ﹤0.01% 2556
2021
Q2
$417K Sell
48,894
-258,654
-84% -$2.65M ﹤0.01% 2587
2021
Q1
$4.71M Buy
307,548
+5,954
+2% +$96.7K ﹤0.01% 1369
2020
Q4
$4.87M Sell
301,594
-5,102
-2% -$76.5K ﹤0.01% 1302
2020
Q3
$4.28M Buy
+306,696
New +$4.57M ﹤0.01% 1216

Other funds holding BCEL

UBS AM's BCEL Position: Q4 2021 in Review

UBS AM sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q4 2021, closing a stake of 67,312 shares — an estimated $419K sold.

UBS AM first reported a position in BCEL in Q3 2020 and held it in 5 quarters. The position peaked at $4.87M in Q4 2020. 100 funds tracked by Wall St. Rank hold BCEL as of Q4 2021.

  • UBS AM reported no remaining Atreca, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • UBS AM sold 67,312 Atreca, Inc. Class A Common Stock shares in Q4 2021, an estimated $419K.
  • UBS AM first reported a position in Atreca, Inc. Class A Common Stock in Q3 2020 and held it in 5 quarters.
  • UBS AM's Atreca, Inc. Class A Common Stock position peaked at $4.87M in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q4 2021.

Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.